US20140221218A1 - Methods for single-molecule analysis - Google Patents

Methods for single-molecule analysis Download PDF

Info

Publication number
US20140221218A1
US20140221218A1 US14/171,369 US201414171369A US2014221218A1 US 20140221218 A1 US20140221218 A1 US 20140221218A1 US 201414171369 A US201414171369 A US 201414171369A US 2014221218 A1 US2014221218 A1 US 2014221218A1
Authority
US
United States
Prior art keywords
dna
label
nicks
nicking
labeling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/171,369
Other languages
English (en)
Inventor
Han Cao
Ming Xiao
Alex Hastie
Michael G. Saghbini
Henry B. Sadowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionano Genomics Inc
Original Assignee
Bionano Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionano Genomics Inc filed Critical Bionano Genomics Inc
Priority to US14/171,369 priority Critical patent/US20140221218A1/en
Assigned to BIONANO GENOMICS, INC. reassignment BIONANO GENOMICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CAO, HAN, XIAO, MING, HASTIE, ALEX, SADOWSKI, HENRY B., SAGHBINI, MICHAEL G.
Publication of US20140221218A1 publication Critical patent/US20140221218A1/en
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIONANO GENOMICS, INC., THE TRUSTEES OF PRINCETON UNIVERSITY
Assigned to BIONANO GENOMICS, INC. reassignment BIONANO GENOMICS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MIDCAP FINANCIAL TRUST, AS AGENT
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Definitions

  • the present invention relates to the field of nanotechnology and to the field of single molecule genomic analysis.
  • NGS Next-generation sequencing
  • NGS platforms generate sequence reads ranging from 25 to more than 500 bases [3], while reads of up to 1000 bases can be obtained by Sanger sequencing with high accuracy. NGS reads are often too short for unambiguous assembly. Paired-end reads can bridge contigs into scaffolds, but there are often gaps within the scaffolds. To order contigs and scaffolds, high-resolution genomic maps from an independent technology platform are needed.
  • Contigs and scaffolds may be difficult to map if they are too short compared to the map resolution. For example, maps may have a resolution of 50-150 kb, while many contigs and scaffolds may only span a few kilobases. Additionally, there are errors in the contigs and scaffolds themselves, often due to misassembly of repeat sequences. Typical medium to large genomes contain 40-85% repetitive sequences [5-8], dramatically hindering effective de novo sequence assembly.
  • BAC-based restriction fragment physical mapping of complex genomes is fairly robust because even in the presence of interspersed repeat sequences along the BAC inserts (typically 100-220 kb long), a unique pattern of restriction fragments is generated.
  • State of the art technologies for physical map construction include SNaPshot [13,14], whole-genome profiling [15,16], optical mapping [17,18], and genome mapping [19].
  • SNaPshot is a restriction fingerprinting method which uses one or more restriction enzymes and fluorescent labels followed by separation of fragments by capillary electrophoresis.
  • SNaPshot has been used for physical mapping of wheat and other genomes [14,20].
  • Optical mapping provides an additional layer of information by retaining the physical order of restriction sites along DNA molecules immobilized on a surface [18]. It has been applied to the maize and the rice genome [11,21].
  • One can validate a sequence assembly by comparing in silico sequence motif maps to consensus optical maps [22-25].
  • information density for optical maps is only about one site per 20 kb, and the technology is limited in utility by high error-rates, non-uniform DNA linearization, and low throughput. Therefore, a high-resolution (e.g., ⁇ 5 kb) DNA sequencing-independent mapping method that can overcome these constraints of optical mapping is much needed.
  • Methods for preparing samples and performing single molecule analysis including methods of mitigating the effects of fragile sites and improving information density for genome mapping, are provided herein.
  • a method of characterizing a DNA comprising: nicking a first DNA at a first sequence motif, wherein the first DNA is double stranded, and wherein the first DNA remains double-stranded adjacent to the nicks; labeling the nicks on the first DNA with a first label; repairing the nicks on the first DNA; marking the repaired first DNA with a second label, wherein the second label is non-sequence-specific, and wherein the second label is different from the first label; linearizing the first DNA following labeling with the first and second labels; and detecting the pattern of the first label on the linearized first DNA.
  • a method of characterizing DNA comprising: nicking a first DNA at a first sequence motif, wherein the first DNA is double stranded, and wherein the first DNA remains double-stranded adjacent to the nicks; labeling the nicks on the first DNA with a first label; repairing the nicks on the first DNA following labeling with the first label; nicking the repaired first DNA at a second sequence motif, wherein the repaired first DNA remains double-stranded adjacent to the nicks; labeling the nicks at the second sequence motif on the first DNA with a second label; repairing the nicks on the first DNA following labeling with the second label; marking the first DNA with a third label, wherein the third label is non-sequence-specific, and wherein the third label is different from the first and second labels; linearizing the first DNA following labeling with the third label; detecting the pattern of at least one of the first and second labels on the first linearized DNA.
  • a method of characterizing DNA comprising: nicking one strand of a first DNA at a recognition sequence with a first nicking endonuclease, wherein the first DNA is double stranded, and wherein the first DNA remains double-stranded adjacent to the nicks; labeling the first DNA at the nicking sites with a first label; repairing the nicks on the first DNA; nicking the complementary strand of a second DNA at the recognition sequence with a second nicking endonuclease, wherein the second DNA is double stranded, and wherein the second DNA remains double-stranded adjacent to the nicks; labeling the second DNA at the nicking sites with a second label; and repairing the nicks on the second DNA.
  • the methods described herein further comprise: nicking one strand of a second DNA at a recognition sequence with the first nicking endonuclease, wherein the second DNA is double stranded, and wherein the second DNA remains double-stranded adjacent to the nicks; labeling the second DNA at the nicking sites repairing the nicks on the second DNA; nicking the complementary strand of the second DNA at the recognition sequence with the second nicking endonuclease; labeling the second DNA at the nicking sites; repairing the nicks on the second DNA; and marking the repaired first and second DNAs with a third label, wherein the third label is a non-sequence-specific label.
  • a method of characterizing DNA comprising: nicking a first DNA at a first sequence motif, wherein the first DNA is double stranded, and wherein the first DNA remains double-stranded adjacent to the nicks; labeling the nicks on the first DNA with a first label; repairing the nicks on the first DNA; tagging the first DNA at a second sequence motif with a second label, wherein the second label does not cut DNA; marking the first DNA with a third label, wherein the third label is a non-sequence-specific label, and wherein the third label is different from the first and second labels; linearizing the first DNA following labeling with the first, second, and third labels; and detecting the first and second labels on the linearized first DNA.
  • a method of characterizing DNA comprising: treating a double-stranded DNA comprising at least one flap on either strand of the DNA with a 5′ to 3′ exonuclease activity of a polymerase under conditions wherein at least one species of dNTP is in present in limited concentration compared to other dNTPs that are present; ligating the nicks to restore strand integrity at flap regions; and characterizing the DNA.
  • a method of characterizing DNA comprising: treating a double-stranded DNA comprising at least one flap on either stand of the DNA with a 5′ to 3′ exonuclease activity of a polymerase under conditions wherein at least one species of dNTP is omitted; ligating the nicks to restore strand integrity at the flap regions; and characterizing the DNA.
  • the methods described herein further comprise: nicking a second DNA at the first sequence motif; labeling the nicks on the second DNA with the first label; repairing the nicks on the second DNA; marking the repaired second DNA with the second label; linearizing the second DNA following labeling with the first and second labels; and detecting the pattern of the first or second label on the linearized second DNA.
  • the methods described herein further comprise: nicking a second DNA at the first sequence motif, wherein the second DNA is double stranded, and wherein the second DNA remains double-stranded adjacent to the nicks; labeling the nicks on the second DNA with the first label; repairing the nicks on the second DNA following labeling with the first label; nicking the repaired second DNA at the second sequence motif, wherein the repaired second DNA remains double-stranded adjacent to the nicks; labeling the nicks at the second sequence motif on the second DNA with the second label; repairing the nicks on the second DNA following labeling with the second label; marking the second DNA with the third label; linearizing the second DNA following labeling with the third label; and detecting the pattern of at least one of the first and second labels on the second linearized DNA.
  • the methods described herein further comprise comparing the pattern of the first label on the first DNA to the pattern of the first label on the second DNA. In some embodiments, the methods described herein further comprise: assembling a plurality of first DNAs using overlap of the labeled sequence motifs to construct a first DNA map; assembling a plurality of second DNAs using overlap of the labeled sequence motifs to construct a second DNA map; and comparing the first DNA map to the second DNA map.
  • the methods described herein further comprise: marking the repaired first and second DNAs with a third label, wherein the third label is a non-sequence-specific label. In some embodiments, the methods described herein further comprise: linearizing the first and second DNAs; detecting the first and second labels on the linearized DNA; and assembling the labeled DNA molecules using overlap of the labeled sequence motifs to construct a DNA map. In some embodiments, the first and second labels are the same label.
  • the methods described herein further comprise: nicking a second DNA at the first sequence motif, wherein the second DNA is double stranded, and wherein the second DNA remains double-stranded adjacent to the nicks; labeling the nicks on the second DNA with the first label; repairing the nicks on the second DNA; tagging the second DNA at the second motif with the second label; marking the second DNA with the third label; linearizing the second DNA following labeling with the first and second labels; and detecting the first and second labels on the linearized second DNA.
  • the linearizing includes transporting the DNA into a nanochannel.
  • the methods described herein further comprise comparing the pattern of at least one of the first or second labels on the first DNA to a pattern of labels on a reference DNA.
  • the methods described herein further comprise comparing the pattern of the first label on the first DNA to a pattern of labels on a reference DNA.
  • the methods described herein further comprise comparing the pattern of the second label on the first DNA to a pattern of labels on a reference DNA, wherein the second label is a sequence specific label.
  • the methods described herein further comprise assembling the labeled first DNA using the pattern of labeled motifs to construct a first DNA map.
  • the methods described herein further comprise assembling the labeled second DNA using the pattern of labeled motifs to construct a first DNA map.
  • the second label is a non-sequence-specific label.
  • the second sequence motif includes at least one binding site for a DNA binding entity selected form the group consisting of a non-cutting restriction enzyme, a zinc finger protein, an antibody, a transcription factor, a transcription activator like domain, a DNA binding protein, a polyamide, a triple helix forming oligonucleotide, and a peptide nucleic acid, wherein the tagging is effected with the binding entity comprising the second label, and wherein the second label is selected form the group consisting of a fluorophore, a quantum dot, a dendrimer, a nanowire, a bead, a hapten, streptavidin, avidin, neutravidin, biotin, and a stabilized reactive group.
  • the second sequence motif includes at least one binding site for a peptide nucleic acid, wherein the tagging is performed with the peptide nucleic acid comprising the second label, and wherein the second label is a fluorophore or a quantum dot.
  • the second sequence motif includes at least one binding site for a methyltransferase, and wherein tagging is performed with the methyltransferase comprising a modified cofactor which includes the second label.
  • the first and second labels are independently selected from the group consisting of a fluorophore, a quantum dot, a dendrimer, a nanowire, a bead, a hapten, a streptavidin, an avidin, a neutravidin, a biotin, and a reactive group. In some embodiments, the first and second labels are independently selected from the group consisting of a fluorophore or a quantum dot. In some embodiments, the labeling is carried out with a polymerase. In some embodiments, the labeling is carried out with a polymerase in the presence of dNTPs comprising the label.
  • the polymerase has a 5′ to 3′ exonuclease activity.
  • the polymerase leaves a flap region, and wherein the flap region is removed to restore a ligatable nick prior to the repairing with a ligase.
  • the flap region is removed using the 5′ to 3′ exonuclease activity of a polymerase under conditions wherein at least one nucleotide is present in limited concentration.
  • the flap region is removed using the 5′ to 3′ exonuclease activity of a polymerase under conditions wherein at least one nucleotide is omitted from the reaction.
  • the flap region is removed with a flap endonuclease.
  • the labeling is carried out with a polymerase in the presence of at least one species of dNTP.
  • the at least one species of dNTP is a single species of dNTP.
  • activity of the polymerase is modulated by adjusting the temperature, dNTP concentration, cofactor concentration, buffer concentration, or any combination thereof, during labeling.
  • FIG. 1 shows fragmentations that can occur at fragile sites as a result of nicking, where nicks are closer to one another ( FIG. 1A ) or farther apart ( FIG. 1B ).
  • FIG. 2 shows DNA length corresponding to the midpoint in a size histogram showing molecules arranged from smallest to largest in length (or mass).(shown as “center of mass”) the percent of DNA molecules that are mapped against a reference genome (shown as “mapping to reference genome”), and the false positive and false negative rates for mapping to a sequenced reference genome compared to a simulation for the same (shown as “false positive” and “false negative”) rates in E.
  • FIG. 3 shows center of mass, percent mapping to a reference genome, and false positive and false negative rates in E. coli subjected to the following treatments: 1.) no repair, or 2) treatment with FEN I to remove flaps followed by a ligase to repair the translated nicks.
  • FIG. 4 shows center of mass, percent mapping to a reference genome, and false positive and false negative rates in Drosophila subjected to the following treatments: 1.) nicking with Nt.BspQI and PreCR repair, and 2.) nicking with Nb.BbVCI and PreCR repair.
  • FIG. 5 shows two-color genome mapping with two enzymes, including the layout of an IrysChip ( 5 A), linearization in nanochannels ( 5 B), distribution of labels at sequence-specific locations ( 5 C), and the alignment of consensus maps ( 5 D) as described in Example 4.
  • Maintaining and restoring the integrity of DNA strands is essential for obtaining long labeled molecules that are useful for complex genome mapping and information density.
  • the methods described herein provide approaches to minimize the formation of fragile DNA sites and fragmentation of DNA, restore the structural integrity of DNA following the use of nicking approaches, and maximize the information content of DNA in order to generate high-resolution maps.
  • Genome mapping on nanochannel arrays at the single-molecule level overcomes many of the limitations of preexisting technologies and is described in depth in Lam ET et al. (Genome mapping on nanochannel arrays for structural variation analysis and sequence assembly, Nat Biotechnol 30: 771-776, 2012), which is hereby incorporated by reference in its entirety.
  • a genome mapping approach allows multiple motifs to be labeled with different colors is employed, significantly increasing information density.
  • a high-resolution physical map is constructed.
  • the physical map can be used to validate or correct a physical map generated using another method, such as SNaPshot fingerprinting technology.
  • the physical map is used to validate assembled regions and correct inaccuracies in sequence scaffolds.
  • the physical map can also be used to facilitate de novo sequence assembly of a region by anchoring sequence scaffolds.
  • the physical map is used to produce a highly accurate and complete sequence assembly.
  • nick labeling is used to prepare DNA for analysis.
  • nicks can move closer to one another (as shown in FIG. 1A ) or farther apart (as shown in FIG. 1B ).
  • Fragmentation can occur at fragile sites due, for example, to: 1) mechanical manipulation, 2) heat required for labeling, 3) strand extension associated with labeling and certain kinds of repair (e.g., using the exonuclease activity of polymerases), or 4) shear forces associated with linearizing DNA molecules.
  • the shorter the distance between nicks the more frequent the fragmentation, particularly if labeling decreases the original distance ( FIG. 1A ).
  • repairing nicks can ameliorate the breakage of DNA.
  • the methods described herein utilize nicking enzymes to create sequence-specific nicks that are subsequently labeled, for example by a fluorescent nucleotide analog.
  • the nick-labeled DNA is stained with the intercalating dye, loaded onto a nanofluidic chip by an electric field, and imaged.
  • the DNA is linearized by confinement in a nanochannel array, resulting in uniform linearization and allowing precise and accurate measurement of the distance between nick-labels on DNA molecules comprising a signature pattern.
  • DNA loading and imaging can be repeated in an automated fashion.
  • a second nicking enzyme is used. In some embodiments, this second nicking enzyme is used with a second label color.
  • reduced driving conditions are used to limit the rate of incorporation of a label, and therefore minimize fragmentation at the fragile sites.
  • reduced driving conditions are used to minimize shearing stress forces associated with DNA elongation.
  • drive is reduced by lowering the concentration of dNTPs, lowering reaction temperature, lowering cofactor concentration, adjusting buffer and salt concentration, or a combination thereof.
  • Drive can be also be reduced at the level of repair by stimulating the exonuclease activity of a polymerase with a high concentration of dNTPs, then limiting extension by restricting or omitting at least one nucleotide (which can be referred to as “choked repair”).
  • a single species of dNTP e.g., dATP
  • the flap is removed with a flap nuclease without extension, and ligation is performed.
  • a suboptimal temperature for a thermophilic polymerase is used to reduce driving conditions.
  • the reaction temperature is about 35° C. to about 75° C., such as 35 ° C., 36° C., 37° C., 38° C., 39° C., 40° C., 41° C., 42° C., 43° C., 44° C., 45° C., 46° C., 47° C., 48° C., 49° C., 50° C., 51° C., 52° C., 53° C., 54° C., 55° C., 56° C., 57° C., 58° C., 59° C., 60° C., 61° C., 62° C., 63° C., 64° C., 65° C., 66° C., 67° C., 68° C., 69° C., 70° C., 71° C., 72° C., 73°
  • the polymerase used herein is thermostable. In some embodiments, the polymerase is mesophilic. In some preferred embodiments, the polymerase does not have a proofreading capability. In some preferred embodiments, the polymerase has a strand displacement capability. In some preferred embodiments, the polymerase has a 5′ to 3′ exonuclease activity. In some preferred embodiments, the polymerase does not have proofreading ability, but does have a strand-displacement capability and a 5′ to 3′ exonuclease activity.
  • nickases that target the same sequence motif but nick at opposite strands are used to target specific DNA strands to minimize the formation of fragile sites.
  • nickases have been modified to only bind to one strand of a double-stranded DNA.
  • nickases are used to target a single strand from a first DNA molecule, and a single strand from a second DNA molecule.
  • a single strand from the first DNA is targeted by a first nickase
  • the complementary strand from the second DNA molecule is targeted with a second nickase that recognizes the same sequence motif as the first nickase.
  • extension from the site of nicking occurs in one direction for a first DNA molecule, and in the opposite direction for a second DNA molecule. In some embodiments, extension from the site of nicking occurs in one direction for a top strand of a DNA molecule, and in the opposite direction for the bottom strand for the same DNA molecule.
  • a reference map is used for assembly as described herein.
  • a plurality of nickases are used to maximize information density.
  • molecules nicked by the plurality of nickases are assembled using a reference map.
  • more than one nicking step is used to maximize information density.
  • the molecule or molecules subjected to more than one nicking step are assembled using a reference map.
  • DNA is linearized.
  • Means of linearizing DNA can include the use of shear force of liquid flow, capillary flow, convective flow, an electrical field, a dielectrical field, a thermal gradient, a magnetic field, combinations thereof (e.g., the use of physical confinement and an electrical field), or any other method known to one of skill in the art.
  • the channel(s) described herein have a cross sectional dimension in the micrometer range.
  • channels have a cross sectional dimension in the nanometer range. Examples of nanochannels and methods incorporating the use of nanochannels are provided in U.S. Publication Nos. 2011/0171634 and 2012/0237936, which are hereby incorporated by reference in their entireties.
  • a second motif is investigated in a molecule of interest.
  • the second motif includes at least one binding site for a binding entity selected from a non-cutting restriction enzyme, a zinc finger protein, an antibody, a transcription factor, a transcription activator like domain, a DNA binding protein, a polyamide, a triple helix forming oligonucleotide, and a peptide nucleic acid.
  • marking or tagging of the second motif is effected with a binding entity comprising a second label.
  • marking is performed with a label that does not cut or nick the DNA.
  • tagging is performed with a label that does not cut or nick the DNA.
  • the second motif includes at least one binding site for a peptide nucleic acid.
  • tagging is effected with a peptide nucleic acid comprising a second label.
  • the second motif includes at least one recognition sequence for a methyltransferase.
  • tagging is performed with a methyltransferase.
  • tagging is performed with a methyltransferase comprising a modified cofactor which includes a second label.
  • a modified cofactor is used.
  • the modified cofactor contains a second label that functions as a transferable tag which becomes covalently coupled to a methyltransferase recognition sequence.
  • the modified cofactor contains a second label that is directly coupled to a methyltransferase recognition sequence.
  • the labels described herein are selected from a fluorophore, a quantum dot, a dendrimer, a nanowire, a bead, a hapten, a streptavidin, an avidin, a neutravidin, a biotin, or a reactive group.
  • the first and second labels described herein are selected from a fluorophore or a quantum dot.
  • labeling is carried out with a polymerase in the presence of at least one labeled dNTP using the process of nick translation.
  • the labeled dNTP preferably contains a fluorophore or a quantum dot.
  • labeling is carried out as described in U.S. Provisional Application No. 61/713,862, which is hereby incorporated by reference in its entirety.
  • the polymerase used herein leaves a flap region that is removed to generate a ligatable nick prior to repair.
  • repair is carried out with a DNA ligase.
  • DNA ligases include Taq DNA ligase, E. coli DNA ligase, T7 DNA ligase, T4 DNA ligase, and 9° N DNA ligase (New England Biolabs).
  • the flap region is removed with an endonuclease.
  • the flap region is removed with a flap endonuclease (e.g., FEN I).
  • the flap region is removed with an exonuclease.
  • the flap region is removed using the 5′ to 3′ exonuclease activity of a polymerase. In some preferred embodiments, the flap region is removed using the 5′ to 3′ exonuclease activity of a polymerase under conditions where at least one of four nucleotides (e.g., dATP, dGTP, dCTP, dTTP/dUTP) is provided in limited concentration. In some preferred embodiments, the flap region is removed using the 5′ to 3′ exonuclease activity of a polymerase under conditions where at least one of the four nucleotides is omitted.
  • four nucleotides e.g., dATP, dGTP, dCTP, dTTP/dUTP
  • the flap region is removed using the 5′ to 3′ exonuclease activity of a Taq polymerase. In some embodiments, the flap is removed to restore ligatability of the translated nick. In some embodiments, the flap region is removed and the nick is repaired using a mixture of enzymes that perform these functions, such as PreCR enzyme mix (New England BioLabs). In some embodiments, the PreCR enzyme mix is used under conditions where at least one of the four nucleotides is provided in limited concentration or omitted.
  • Nucleotides that are not omitted during the flap removal process can be present at a concentration of about 25 nM to about 50 nM each, about 50 nM to about 100 nM, about 100 nM to about 200 nM, about 200 nM to about 400 nM, about 400 nM to about 800 nM, about 800 nM to about 1.6 uM, about 1.6 uM to about 3.2 uM, about 3.2 uM to about 6.4uM, about 6.4 uM to about 12.8 uM, about 12.8 uM to about 25.6 uM, about 25.6 uM to about 51.2 uM, about 51.2 uM to about 102.4 uM, about 102.4uM to about 204.8 uM, about 204.8 uM to about 409.6 uM, and about 409.6 uM to about 819.2 uM, about 819.2 uM to about 1638.4 uM, or about 1638.4 uM
  • the at least one nucleotide that is limited in concentration is at a concentration at least 2 ⁇ less, at least 5 ⁇ less, at least 10 ⁇ less, at least 20 ⁇ , at least 30 ⁇ less, at least 60 ⁇ less, at least 100 ⁇ , at least 500 ⁇ less, at least 1000 ⁇ less, or at least 3000 ⁇ less than at least one of the other nucleotides that is present.
  • the at least one nucleotide that is limited in concentration is at a concentration that is negligible compared to the nucleotides that are present.
  • the at least one nucleotides that is limited in concentration is at a concentration at least 100 ⁇ less that the nucleotides that are present.
  • a method for repairing flap-containing DNA is provided.
  • at least one nucleotide is omitted prior to DNA characterization.
  • the method entails treating a double stranded DNA containing at least one flap on either stand of the DNA with a 5′ to 3′ exonuclease activity of a polymerase under conditions wherein at least one nucleotide is omitted, ligating the nicks to restore strand integrity at the flap regions, and characterizing the DNA.
  • at least one nucleotide is limited in concentration prior to DNA characterization.
  • the method entails treating a double stranded DNA comprising at least one flap on either stand of the DNA with a 5′ to 3′ exonuclease activity of a polymerase under conditions wherein at least one nucleotide is limited in concentration, ligating the nicks to restore strand integrity at the flap regions, and characterizing the DNA.
  • Methods for characterizing the molecules described herein include any method for determining the information content of the DNA, such as sequencing, mapping, single nucleotide polymorphism (SNP) analysis, copy number variant (CNV) analysis, haplotyping, or epigenetic analysis.
  • SNP single nucleotide polymorphism
  • CNV copy number variant
  • the DNA described herein can be of any length (e.g., 0.1 Kb to a mega base).
  • the DNA can be a highly pure preparation, crude, or semi-crude material.
  • the DNA can come from any biological source or can be synthetic.
  • polymerase refers to any enzyme, naturally occurring or engineered, that is capable of incorporating native and modified nucleotides in a template dependent manner starting at a 3′ hydroxyl end.
  • nicking endonuclease refers to any enzyme, naturally occurring or engineered, that is capable of breaking a phosphodiester bond on a single DNA strand, leaving a 3′-hydroxyl at a defined sequence.
  • nicking endonucleases can be engineered by modifying restriction enzymes to eliminate cutting activity for one DNA strand, or produced by fusing a nicking subunit to a DNA binding domain, for example, zinc fingers and DNA recognition domains from transcription activator-like effectors.
  • E. coli genomic DNA was nicked with Nt.BspQI nicking endonuclease.
  • the nicked DNA was labeled with Taq polymerase by nick translation using Atto dUTP or Alexa dUTP in the presence of cold dATP, dGTP, and dCTP.
  • the labeled nicks were: 1.) not repaired, 2.) repaired with PreCR as recommended by manufacture (New England BioLabs), 3.) repaired with PreCR under conditions of omitting dGTP, 4.) repaired with PreCR under conditions of omitting dATP and dGTP, or 5.) repaired with Taq polymerase under conditions of omitting dGTP. Ligation was then performed with a ligase.
  • the resulting DNA was stained with YOYO-1 (Life Technologies) and processed on the Irys system (BioNano Genomics). Briefly, DNA was linearized in massively parallel nanochannels, excited with the appropriate laser for backbone and label detection, and optically imaged. Mapping to a reference genome, center of mass, and False Positive (FP) and False Negative (FN) calculations were carried out using nano Studio data analysis software (BioNano Genomics). Results are shown in FIG. 2 .
  • E. coli genomic DNA was nicked with Nt.BspQI nicking endonuclease.
  • the nicked DNA was labeled with Taq polymerase by nick translation using Atto dUTP.
  • the labeled DNA was: 1.) left unrepaired or 2.) treated with FEN Ito remove flaps followed by a ligase to repair the translated nicks.
  • the DNA was linearized in massively parallel nanochannels, excited with the appropriate laser for backbone and label detection, and optically imaged. Mapping to a reference genome, center of mass, and False Positive (FP) and False Negative (FN) calculations were carried out using nano Studio data analysis software (BioNano Genomics). Results are shown in FIG. 3 .
  • Drosophila genomic DNA was nicked with Nt.BspQI or Nb.BbVCI nicking endonuclease.
  • the nicked DNA was labeled with Taq polymerase by nick translation using Atto dUTP.
  • the labeled DNA was treated with PReCR reagent (New England Biolabs) to repair the nicks.
  • the resulting DNA was stained with YOYO-1 (Life Technologies) and processed on the Irys system (BioNano Genomics). Mapping to a reference genome, center of mass, and False Positive (FP) and False Negative (FN) calculations were carried out using nano Studio data analysis software (BioNano Genomics). Results are shown in FIG. 4 .
  • FIG. 5A shows the layout of the IrysChip (BioNano Genomics).
  • the YOYO-stained DNA was loaded into the port, unwound within the pillar structures, and linearized inside 45 nm nanochannels ( FIG. 5B ).
  • individual BAC molecules with red and green labels distributed at sequence-specific locations were compared and clustered into pools with similar map patterns ( FIG. 5C , top).
  • Density plots for the BAC clones were generated to determine the consensus peak locations ( FIG. 5C , bottom).
  • the consensus maps of individual BAC clones were aligned based on overlaps of consensus maps of adjacent BACs ( FIG. 5D ) to create a genome map of the entire region.
  • the two-color labeling strategy resulted in an average information density of one label per 4.8 kb (437 labels in 2.1 Mb). Since each motif was marked by its own color, peaks of different motifs could be distinguished from each other even if their peaks were almost overlapping (arrow in FIG. 5D ). Peaks of the same motif (i.e., the same color) could be resolved when they were at least ⁇ 1.5 kb apart. Taking advantage of the combination of long molecule lengths ( ⁇ 140 kb average), high-resolution, accurate length measurement, and multiple sequence motifs, a high-quality genome map of the 2.1-Mb region for scaffold assembly was generated.
  • McPherson TIHGMCJD (2001) A physical map of the human genome. Nature 409: 934-941.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
US14/171,369 2013-02-05 2014-02-03 Methods for single-molecule analysis Abandoned US20140221218A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/171,369 US20140221218A1 (en) 2013-02-05 2014-02-03 Methods for single-molecule analysis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361761189P 2013-02-05 2013-02-05
US14/171,369 US20140221218A1 (en) 2013-02-05 2014-02-03 Methods for single-molecule analysis

Publications (1)

Publication Number Publication Date
US20140221218A1 true US20140221218A1 (en) 2014-08-07

Family

ID=51259712

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/765,537 Pending US20150368706A1 (en) 2013-02-05 2014-02-03 Methods for single-molecule analysis
US14/171,369 Abandoned US20140221218A1 (en) 2013-02-05 2014-02-03 Methods for single-molecule analysis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/765,537 Pending US20150368706A1 (en) 2013-02-05 2014-02-03 Methods for single-molecule analysis

Country Status (8)

Country Link
US (2) US20150368706A1 (ja)
EP (1) EP2954069B1 (ja)
JP (1) JP6475171B2 (ja)
CN (1) CN105143462A (ja)
AU (2) AU2014215586A1 (ja)
CA (1) CA2900054A1 (ja)
HK (1) HK1217735A1 (ja)
WO (1) WO2014123822A1 (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9310376B2 (en) 2007-03-28 2016-04-12 Bionano Genomics, Inc. Methods of macromolecular analysis using nanochannel arrays
US9536041B2 (en) 2008-06-30 2017-01-03 Bionano Genomics, Inc. Methods and devices for single-molecule whole genome analysis
US9845238B2 (en) 2006-07-19 2017-12-19 Bionano Genomics, Inc. Nanonozzle device arrays: their preparation and use for macromolecular analysis
US10000803B2 (en) 2008-11-18 2018-06-19 Bionano Genomics, Inc. Polynucleotide mapping and sequencing
US11427858B2 (en) * 2017-07-31 2022-08-30 Technion Research & Development Foundation Limited Methods of detecting modified and unmodified DNA
US11959134B2 (en) * 2014-02-18 2024-04-16 Bionano Genomics, Inc. Methods of determining nucleic acid structural information

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10844424B2 (en) 2013-02-20 2020-11-24 Bionano Genomics, Inc. Reduction of bias in genomic coverage measurements
WO2015130696A1 (en) 2014-02-25 2015-09-03 Bionano Genomics, Inc. Reduction of bias in genomic coverage measurements
CA2901460A1 (en) 2013-02-20 2014-08-28 Bionano Genomics, Inc. Characterization of molecules in nanofluidics
EP3497239A4 (en) * 2016-08-10 2020-02-26 Ramot at Tel-Aviv University Ltd. METHYLATION STATUS ANALYSIS AND COPY NUMBER
EP4276197A3 (en) * 2017-11-16 2024-01-17 New England Biolabs, Inc. Mapping the location, type and strand of damaged nucleotides in double-stranded dna
US11149298B2 (en) 2018-06-13 2021-10-19 International Business Machines Corporation Detection of nucleic acid sequences using deterministic lateral displacement arrays
US11180796B2 (en) 2018-06-13 2021-11-23 International Business Machines Corporation Detection of mutations regarding one or more deoxyribonucleic acid sequences using deterministic lateral displacement arrays
EP4172366A1 (en) 2020-06-25 2023-05-03 Perseus Biomics BV Kit and methods for characterizing a virus in a sample
WO2024145269A1 (en) 2022-12-25 2024-07-04 Bionano Genomics, Inc. Optical genome mapping system
WO2024145270A1 (en) 2022-12-25 2024-07-04 Bionano Genomics, Inc. Instrumentation of optical genome mapping systems
WO2024145268A2 (en) 2022-12-25 2024-07-04 Bionano Genomics, Inc. Optical genome mapping cartridges

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148674A1 (en) * 2005-12-23 2007-06-28 Wisconsin Alumni Research Foundation (Warf) Optical fingerprinting of nucleic acid sequences
US20090305273A1 (en) * 2006-07-19 2009-12-10 Bionanomatrix, Inc. Nanonozzle device arrays: their preparation and use for macromolecular analysis
US7771944B2 (en) * 2007-12-14 2010-08-10 The Board Of Trustees Of The University Of Illinois Methods for determining genetic haplotypes and DNA mapping
US20100330557A1 (en) * 2009-06-30 2010-12-30 Zohar Yakhini Genomic coordinate system
US7960105B2 (en) * 2005-11-29 2011-06-14 National Institutes Of Health Method of DNA analysis using micro/nanochannel
US20110171634A1 (en) * 2008-06-30 2011-07-14 Bionanomatrix, Inc. Methods and devices for single-molecule whole genome analysis
US20110296903A1 (en) * 2008-06-02 2011-12-08 Bionanomatrix, Inc. Integrated analysis devices and related fabrication methods and analysis techniques
US20120237936A1 (en) * 2009-10-21 2012-09-20 Bionano Genomics, Inc. Methods and related devices for single molecule whole genome analysis
US20120322058A1 (en) * 2011-02-09 2012-12-20 Bio-Rad Laboratories Analysis of nucleic acids

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521509A (en) * 1982-11-24 1985-06-04 Research Corporation Method for degrading DNA
US5736334A (en) * 1993-04-12 1998-04-07 Abbott Laboratories Nucleotide sequences and process for amplifying and detection of hepatitis B viral DNA
FR2716263B1 (fr) * 1994-02-11 1997-01-17 Pasteur Institut Procédé d'alignement de macromolécules par passage d'un ménisque et applications dans un procédé de mise en évidence, séparation et/ou dosage d'une macromolécule dans un échantillon.
US7270958B2 (en) * 1998-09-10 2007-09-18 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
US20020187508A1 (en) * 2001-06-08 2002-12-12 Wong Gordon G. Methods and products for analyzing nucleic acids using nick translation
US6613523B2 (en) * 2001-06-29 2003-09-02 Agilent Technologies, Inc. Method of DNA sequencing using cleavable tags
WO2003055975A2 (en) * 2001-08-23 2003-07-10 New England Biolabs, Inc. A method for engineering strand-specific, sequence-specific, dna-nicking enzymes
US7393635B2 (en) * 2002-05-16 2008-07-01 Dna Polymerase Technology, Inc. Ribocloning: recombinant DNA construction using primers with ribo bases
US20050019784A1 (en) * 2002-05-20 2005-01-27 Xing Su Method and apparatus for nucleic acid sequencing and identification
US8158388B2 (en) * 2004-10-21 2012-04-17 New England Biolabs, Inc. Repair of nucleic acids for improved amplification
US7862999B2 (en) * 2007-01-17 2011-01-04 Affymetrix, Inc. Multiplex targeted amplification using flap nuclease
AU2008232616B2 (en) * 2007-03-28 2014-08-07 Bionano Genomics, Inc. Methods of macromolecular analysis using nanochannel arrays
US9689031B2 (en) * 2007-07-14 2017-06-27 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
WO2009052214A2 (en) * 2007-10-15 2009-04-23 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
US10670559B2 (en) * 2008-07-11 2020-06-02 Cornell University Nanofluidic channels with integrated charge sensors and methods based thereon
WO2010042007A1 (en) * 2008-10-10 2010-04-15 Jonas Tegenfeldt Method for the mapping of the local at/gc ratio along dna
US8017328B2 (en) * 2008-11-21 2011-09-13 Agilent Technologies, Inc. Genome partitioning using a nicking endonuclease
US20100330556A1 (en) * 2009-06-30 2010-12-30 Brian Jon Peter Genome analysis using a nicking endonuclease
US8722585B2 (en) * 2011-05-08 2014-05-13 Yan Wang Methods of making di-tagged DNA libraries from DNA or RNA using double-tagged oligonucleotides
WO2012166647A1 (en) * 2011-05-27 2012-12-06 Life Technologies Corporation Methods for manipulating biomolecules
US9139874B2 (en) * 2011-07-07 2015-09-22 Life Technologies Corporation Bi-directional sequencing compositions and methods

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960105B2 (en) * 2005-11-29 2011-06-14 National Institutes Of Health Method of DNA analysis using micro/nanochannel
US20070148674A1 (en) * 2005-12-23 2007-06-28 Wisconsin Alumni Research Foundation (Warf) Optical fingerprinting of nucleic acid sequences
US20090305273A1 (en) * 2006-07-19 2009-12-10 Bionanomatrix, Inc. Nanonozzle device arrays: their preparation and use for macromolecular analysis
US7771944B2 (en) * 2007-12-14 2010-08-10 The Board Of Trustees Of The University Of Illinois Methods for determining genetic haplotypes and DNA mapping
US20110296903A1 (en) * 2008-06-02 2011-12-08 Bionanomatrix, Inc. Integrated analysis devices and related fabrication methods and analysis techniques
US20110171634A1 (en) * 2008-06-30 2011-07-14 Bionanomatrix, Inc. Methods and devices for single-molecule whole genome analysis
US20100330557A1 (en) * 2009-06-30 2010-12-30 Zohar Yakhini Genomic coordinate system
US20120237936A1 (en) * 2009-10-21 2012-09-20 Bionano Genomics, Inc. Methods and related devices for single molecule whole genome analysis
US20120322058A1 (en) * 2011-02-09 2012-12-20 Bio-Rad Laboratories Analysis of nucleic acids

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9845238B2 (en) 2006-07-19 2017-12-19 Bionano Genomics, Inc. Nanonozzle device arrays: their preparation and use for macromolecular analysis
US11529630B2 (en) 2006-07-19 2022-12-20 Bionano Genomics, Inc. Nanonozzle device arrays: their preparation and use for macromolecular analysis
US9310376B2 (en) 2007-03-28 2016-04-12 Bionano Genomics, Inc. Methods of macromolecular analysis using nanochannel arrays
US10000804B2 (en) 2007-03-28 2018-06-19 Bionano Genomics, Inc. Methods of macromolecular analysis using nanochannel arrays
US9536041B2 (en) 2008-06-30 2017-01-03 Bionano Genomics, Inc. Methods and devices for single-molecule whole genome analysis
US10435739B2 (en) 2008-06-30 2019-10-08 Bionano Genomics, Inc. Methods and devices for single-molecule whole genome analysis
US10995364B2 (en) 2008-06-30 2021-05-04 Bionano Genomics, Inc. Methods and devices for single-molecule whole genome analysis
US11939627B2 (en) 2008-06-30 2024-03-26 Bionano Genomics, Inc. Methods and devices for single-molecule whole genome analysis
US10000803B2 (en) 2008-11-18 2018-06-19 Bionano Genomics, Inc. Polynucleotide mapping and sequencing
US11959134B2 (en) * 2014-02-18 2024-04-16 Bionano Genomics, Inc. Methods of determining nucleic acid structural information
US12054771B2 (en) * 2014-02-18 2024-08-06 Bionano Genomics, Inc. Methods of determining nucleic acid structural information
US11427858B2 (en) * 2017-07-31 2022-08-30 Technion Research & Development Foundation Limited Methods of detecting modified and unmodified DNA

Also Published As

Publication number Publication date
CN105143462A (zh) 2015-12-09
EP2954069A1 (en) 2015-12-16
HK1217735A1 (zh) 2017-01-20
EP2954069A4 (en) 2016-09-14
AU2020201280A1 (en) 2020-03-12
AU2020201280B2 (en) 2022-04-07
CA2900054A1 (en) 2014-08-14
US20150368706A1 (en) 2015-12-24
WO2014123822A1 (en) 2014-08-14
EP2954069B1 (en) 2020-11-11
JP2016507239A (ja) 2016-03-10
JP6475171B2 (ja) 2019-02-27
AU2014215586A1 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
AU2020201280B2 (en) Methods for single-molecule analysis
US10704091B2 (en) Genotyping by next-generation sequencing
EP2427569B1 (en) The use of class iib restriction endonucleases in 2nd generation sequencing applications
JP2023071981A (ja) 酵素不要及び増幅不要の配列決定
EP2663655B1 (en) Paired end random sequence based genotyping
US20170298431A1 (en) Nucleic acid sample enrichment for sequencing applications
ES2352987T3 (es) Cartografía física de alto rendimiento utilizando aflp.
JP7332733B2 (ja) 次世代シークエンシングのための高分子量ｄｎａサンプル追跡タグ
Dames et al. Comparison of the Illumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes
CA3128098A1 (en) Haplotagging - haplotype phasing and single-tube combinatorial barcoding of nucleic acid molecules using bead-immobilized tn5 transposase
JP2023519782A (ja) 標的化された配列決定の方法
TWI715900B (zh) 次世代定序儀用引子以及其製造方法、使用次世代定序儀用引子之ｄｎａ庫以及其製造方法，及使用ｄｎａ庫之基因體ｄｎａ解析方法
EP2032721A1 (en) Nucleic acid concatenation
WO2023196572A1 (en) Altered cytidine deaminases and methods of use
KR102237248B1 (ko) 소나무 개체식별 및 집단의 유전 분석용 snp 마커 세트 및 이의 용도
Varapula et al. Recent Applications of CRISPR-Cas9 in Genome Mapping and Sequencing
Feng Comprehensive Sequencing with Surface Tagmentation Based Technology
CN108251517A (zh) 一种分析体系内相似序列相对数量的方法
Blattner Single cell transcriptome analysis using next generation sequencing.
WO2005038026A1 (ja) 変異のタイピング方法

Legal Events

Date Code Title Description
AS Assignment

Owner name: BIONANO GENOMICS, INC., PENNSYLVANIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CAO, HAN;XIAO, MING;HASTIE, ALEX;AND OTHERS;SIGNING DATES FROM 20140416 TO 20140428;REEL/FRAME:033029/0662

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: MIDCAP FINANCIAL TRUST, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:BIONANO GENOMICS, INC.;THE TRUSTEES OF PRINCETON UNIVERSITY;REEL/FRAME:046472/0643

Effective date: 20180629

AS Assignment

Owner name: BIONANO GENOMICS, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST, AS AGENT;REEL/FRAME:048674/0556

Effective date: 20190322